Daniel I. Simon

Patients With Diabetes at High Bleeding Risk With 1-Month Dual Antiplatelet Therapy: Onyx ONE Clear Results

M. Price, G. Stone, A. Kirtane, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Coronary Stenting in Patients With Small Coronary Arteries at High Risk of Bleeding: Onyx ONE Clear

M. Price, G. Stone, T. Nazif, 2022, Journal of the Society for Cardiovascular Angiography & Interventions.

Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size.

K. Preissner, J. Jakowitsch, J. Mascherbauer, 2015, Circulation research.

Mild Therapeutic Hypothermia Alters Hemostasis in ST Elevation Myocardial Infarction Patients

A. Mangold, I. Lang, T. Hofbauer, 2021, Frontiers in Cardiovascular Medicine.

Rationale and design of the Onyx ONE global randomized trial: A randomized controlled trial of high-bleeding risk patients after stent placement with 1â• ̄month of dual antiplatelet therapy

M. Price, G. Stone, R. Mehran, 2019 .